Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1960 Dec;39(12):1813–1817. doi: 10.1172/JCI104205

SUSCEPTIBILITY TO EXPERIMENTAL PYELONEPHRITIS WHEN HORMONAL HYPERTENSION IS PREVENTED BY HYPOTENSIVE DRUGS *

James W Woods 1
PMCID: PMC441906  PMID: 13786573

Full text

PDF
1813

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GARDNER D. L. The relationship between intermittent hypotension and the prevention by hydralazine of acute vascular disease in rats with steroid hypertension. Br J Exp Pathol. 1960 Feb;41:60–71. [PMC free article] [PubMed] [Google Scholar]
  2. GAUNT R., ANTONCHAK N., MILLER G. J., RENZI A. A. Effect of reserpine (serpasil) and hydralazine (apresoline) on experimental steroid hypertension. Am J Physiol. 1955 Jul;182(1):63–68. doi: 10.1152/ajplegacy.1955.182.1.63. [DOI] [PubMed] [Google Scholar]
  3. GOLDBLATT H. Pathogenesis of malignant hypertension. Circulation. 1957 Nov;16(5):697–699. doi: 10.1161/01.cir.16.5.697. [DOI] [PubMed] [Google Scholar]
  4. GROSS F., NOELPP B., SULSER F., DOEBELIN R., KUNDIG H. Vergleichende Untersuchungen über die medikamentöse Beeinflussung verschiedener Formen von experimenteller Hypertension. Klin Wochenschr. 1955 Apr 15;33(15-16):372–378. doi: 10.1007/BF01467970. [DOI] [PubMed] [Google Scholar]
  5. MASSON G. M., McCORMACK L. J., DUSTAN H. P., CORCORAN A. C. Hypertensive vascular disease as a consequence of increased arterial pressure; quantitative study in rats with hydralazine-treated renal hypertension. Am J Pathol. 1958 Sep-Oct;34(5):817–833. [PMC free article] [PubMed] [Google Scholar]
  6. Selye H., Hall C. E., Rowley E. M. Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride. Can Med Assoc J. 1943 Aug;49(2):88–92. [PMC free article] [PubMed] [Google Scholar]
  7. WOODS J. W. Susceptibility of rats with hormonal hypertension to experimental pyelonephritis. J Clin Invest. 1958 Dec;37(12):1686–1692. doi: 10.1172/JCI103760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. WOODS J. W., WELT L. G., HOLLANDER W., Jr, NEWTON M. Susceptibility of rats to experimental pyelonephritis following recovery from potassium depletion. J Clin Invest. 1960 Jan;39:28–33. doi: 10.1172/JCI104023. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES